Characterization of extracellular vesicles in COVID-19 infection during pregnancy

Keyphrases

• Infections In Pregnancy 100%
• Extracellular Vesicles 100%
• COVID-19 Infection 100%
• Non-pregnant Women 47%
• COVID-19 41%
• COVID-19 Positive 17%
• Disease Course 11%
• Pregnancy Outcome 11%
• Inflammatory Response 11%
• Blood Samples 5%
• Pregnant Women 5%
• Third Trimester 5%
• Immunosuppression 5%
• Fibrinogen 5%
• Endothelial Markers 5%
• Interleukin-2 5%
• Cytotoxic T Cells 5%
• CD8+ 5%
• CD62P 5%
• Coagulation System 5%
• IL-6 Level 5%
• Exosomes 5%
• CD63 5%
• Marker Expression 5%
• Angiotensin-converting Enzyme 2 (ACE2) 5%
• Hypercoagulability 5%
• Transmembrane Protease Serine 2 (TMPRSS2) 5%
• SARS-CoV-2 Infection 5%
• Moderate Disease 5%
• Course Outcomes 5%
• D-dimer 5%
• Severe Morbidity 5%
• T-cell Markers 5%
• SARS-CoV-2 Entry 5%
• Immune Components 5%
• CD144 5%
• Pregnant Women's Experiences 5%
• Coagulation Markers 5%
• Platelet Activation Markers 5%
• Mild COVID-19 Infection 5%

Immunology and Microbiology

• COVID-19 100%
• Inflammation Response 15%
• Severe Acute Respiratory Syndrome Coronavirus 2 15%
• Cytokine 7%
• Cell Marker 7%
• Cytotoxic T Cell 7%
• CD8 7%
• Fibrinogen 7%
• Interleukin-6 7%
• Immunosuppression 7%
• Exosome 7%
• CD63 7%
• Third Trimester Pregnancy 7%
• Blood Clotting 7%
• Thrombocyte Activation 7%